Is Cell Reports a Good Journal? What Scientists Actually Think

Cell Reports has an impact factor of 6.9 and is published by Cell Press, the same publisher behind Cell, Molecular Cell, and about a dozen other respected life sciences journals. It's a real journal with real peer review and a genuine place in the scientific literature.

But researchers frequently ask whether it's actually worth targeting. The APC is $5,790. The IF is lower than Nature Communications. It lives in the shadow of its famous parent, Cell. So is it a good journal, or is it just trading on a famous name?

Here's an honest take.

What Cell Reports Is Designed For

Cell Reports launched in 2012 with a specific editorial philosophy: publish complete, data-rich studies that tell a full mechanistic story. The emphasis is on thoroughness. A Cell Reports paper isn't supposed to be a single striking finding - it's supposed to be a convincing, thorough investigation of a biological question.

This is the "Report" format advantage. Cell Press editors at Cell Reports expect multiple lines of evidence, appropriate controls, and a story that doesn't leave major mechanistic gaps open. In practice, this means papers are often longer and more data-dense than you'd see at many other journals.

For researchers who have that kind of complete story, Cell Reports is an excellent home. For researchers sitting on a strong preliminary finding that needs more work, it's probably not ready.

The Impact Factor: 6.9 in Context

The impact factor of 6.9 is solid but not spectacular. Here's how it compares to journals competing for similar manuscripts:

The honest read: 6.9 is good, but the APC doesn't match the IF. You're paying Nature Communications prices for a journal ranked well below it by impact factor. The Cell Press brand is doing work here. Whether that brand premium justifies the price depends on your field and career stage.

In cell biology, developmental biology, and molecular biology, Cell Reports is widely respected and the brand carries real meaning. In fields where Cell Press isn't the dominant publisher, the calculus shifts.

Why the IF Doesn't Tell the Whole Story

Impact factors disadvantage specialty journals. Cell Reports publishes primarily in life sciences, which means it draws citations from a narrower pool than multidisciplinary journals like Nature Communications or Science Advances. An IF of 6.9 in life sciences actually reflects strong citation performance.

Field-normalized metrics like the SNIP (Source Normalized Impact per Paper) paint a more favorable picture for Cell Reports than the raw IF does. Many hiring committees in biology understand this.

The Cell Press Brand: Does It Actually Help?

This is where Cell Reports genuinely earns its place. Cell Press is one of the most respected brands in life sciences publishing. When a hiring committee in cell or molecular biology sees a Cell Reports paper, they know immediately what they're looking at - a rigorous, complete study from a publisher with editorial standards they trust.

That brand recognition is worth something. It's not worth $5,790 by itself, but combined with the genuine editorial quality and peer review process, it makes Cell Reports a meaningful publication.

The comparison to its parent, Cell, matters here. Cell is extraordinarily hard to publish in. Most labs that would be candidates for Cell regularly publish in Cell Reports instead. It functions as the "strong but not flagship" home for Cell Press's stable of journals.

The Report Format: Advantage or Burden?

Cell Reports expects complete stories. That's both the appeal and the challenge.

The advantage: If your paper is mechanistically thorough, Cell Reports reviewers will recognize and reward that. You're less likely to get requests to add entirely new experimental arms to your study, because the expectation of completeness is built in from submission. Reviewers know what the journal asks for.

The challenge: If your story has gaps, you'll be asked to fill them. Cell Reports reviewers are not gentle about mechanistic holes. Papers routinely go through one or two major revision rounds involving substantial new experiments. Plan for a 6-12 month total timeline from submission to acceptance if your paper goes to full review.

The review time at Cell Reports is not fast. First decisions arrive in 5-7 days (fast desk rejection or peer review routing), but the overall process from submission to acceptance averages 3-6 months.

Who Publishes in Cell Reports

Looking at the actual output:

• Labs in cell biology, molecular biology, neuroscience, immunology, cancer biology
• Studies with 5-8 figures of primary data (not preliminary 2-figure findings)
• Research from established labs with the capacity to do thorough follow-up experiments
• Work from both academic medical centers and basic research institutions

Early-career first authors do appear. But the papers tend to be from labs with the resources to run thorough, multi-experiment studies. This isn't a bias in peer review - it's a consequence of the journal's thoroughness expectations.

The Acceptance Rate and Desk Rejection

The overall acceptance rate is around 15%. Desk rejection happens frequently, usually within 5-7 days.

Common reasons for desk rejection at Cell Reports:

• Insufficient mechanistic depth (the story doesn't explain "how" or "why")
• Scope too narrow for broad biological significance
• Missing key controls that the completeness standard demands
• Work primarily of interest to specialists in a single niche

If you receive a desk rejection, don't interpret it as a judgment that your science is wrong. It usually means the editors saw a gap between where the story is and where it needs to be for Cell Reports' bar.

When Cell Reports Is the Right Choice

Target Cell Reports when:

• You're in cell/molecular biology, neuroscience, immunology, or cancer biology
• Your paper is mechanistically complete with multiple independent lines of evidence
• Your institution has read-and-publish access to Cell Press (eliminates the APC concern)
• You want Cell Press brand recognition without competing against CNS-level papers

Don't target Cell Reports when:

• Your story is early-stage or still needs follow-up experiments
• Your field is outside the Cell Press sweet spot (physics, earth sciences, clinical research)
• You're on a tight budget and the APC is uncovered
• You want a faster review timeline - there are faster options with comparable IFs

The APC Problem

Let's be direct: $5,790 is hard to justify for an IF-6.9 journal when alternatives exist.

Science Advances costs $5,000 for an IF of 12.5. PLOS Biology costs $5,000 for an IF of roughly 9.8. The Journal of Clinical Investigation costs $2,500 for an IF of around 11.

If you're choosing Cell Reports for the Cell Press brand recognition in your field and your institution covers the cost, that's a defensible choice. If you're paying out-of-pocket and purely optimizing for impact factor per dollar, there are better options.

The strongest case for Cell Reports is researchers in biology who want the Cell Press stamp and whose institutions have deals. In that scenario, it's an excellent target.

Getting Your Submission Ready

If you're targeting Cell Reports, the cover letter needs to make two things clear: the broad biological significance, and the mechanistic completeness of the story. Editors making fast desk-rejection decisions are reading cover letters to see whether the paper meets the bar before they even look at the manuscript.

The Bottom Line

Cell Reports is a good journal. It's rigorous, well-respected in life sciences, and the Cell Press brand carries genuine weight.

The IF of 6.9 is solid but lower than journals with similar APCs. You're paying partly for the brand, partly for the thorough peer review process, and partly for being in the Cell Press ecosystem.

It's the right target for mechanistically complete stories in biology from labs with the resources to meet the completeness expectation. It's not the right target for early-stage work, out-of-pocket APC situations, or fields outside the Cell Press wheelhouse.

The STAR Methods Requirement

Cell Reports requires authors to use a structured methods format called STAR Methods (Structured, Transparent, Accessible Reporting). This isn't optional.

STAR Methods separates the methods into clearly labeled subsections: Key Resources Table (listing all reagents, cell lines, software, and organisms with catalog numbers and sources), a Method Details section, and a Quantification and Statistical Analysis section.

This matters practically because:

• Reviewers at Cell Reports expect the structured format and will flag its absence
• The Key Resources Table is scrutinized for reproducibility: every antibody needs a catalog number, every cell line needs a source
• Statistical reporting needs to be explicit: sample sizes, test selection rationale, and what each n represents must be stated clearly

If you're converting a paper formatted for another journal to Cell Reports format, budget time for properly building the STAR Methods section. It adds 2-4 hours of work but is non-negotiable for peer review.

For a full submission guide and editor preferences, see the Cell Reports journal profile.

Sources

• Clarivate Journal Citation Reports 2025 (2024 IF data)
• Cell Press Author Resources: cell.com/cell-reports/authors
• Cell Reports impact factor history
• Cell Reports acceptance rate analysis
• Review time at Cell Reports
• Full Cell Reports journal profile

See also

• Cell Reports Impact Factor 2026
• Cell Reports Review Time
• Cell Reports Acceptance Rate
• How to Submit to Cell Journal